Theyre also not available in every state due to legal restrictions
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity), along with tirzepatide (Mounjaro, Zepbound)a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonistare effective medications for type 2 diabetes and weight management
Theres no known interaction between Wegovy and Wellbutrin
Incretin-mimetic drugs for obesity, such as semaglutide and tirzepatide, may lead to significant muscle mass loss
The latest SUSTAIN trial was published in 2022 that showed semaglutide once a week led to greater HBA1C reduction as compared to insulin aspart thrice per day